title: Phase III randomized trial of sunitinib versus capecitabine in patients with previously treated HER2-negative advanced breast cancer.
authors.affiliation: PUCRS School of Medicine, Centro de Pesquisa em Oncologia, Jardim Botanico, Porto Alegre, RS, 90610-000, Brazil. chbe@via-rs.net
authors.forename: Carlos H
authors.initials: CH
authors.lastname: Barrios
authors.forename: Mei-Ching
authors.initials: MC
authors.lastname: Liu
authors.forename: Soo Chin
authors.initials: SC
authors.lastname: Lee
authors.forename: Laurence
authors.initials: L
authors.lastname: Vanlemmens
authors.forename: Jean-Marc
authors.initials: JM
authors.lastname: Ferrero
authors.forename: Toshio
authors.initials: T
authors.lastname: Tabei
authors.forename: Xavier
authors.initials: X
authors.lastname: Pivot
authors.forename: Hiroji
authors.initials: H
authors.lastname: Iwata
authors.forename: Kenjiro
authors.initials: K
authors.lastname: Aogi
authors.forename: Roberto
authors.initials: R
authors.lastname: Lugo-Quintana
authors.forename: Nadia
authors.initials: N
authors.lastname: Harbeck
authors.forename: Marla J
authors.initials: MJ
authors.lastname: Brickman
authors.forename: Ke
authors.initials: K
authors.lastname: Zhang
authors.forename: Kenneth A
authors.initials: KA
authors.lastname: Kern
authors.forename: Miguel
authors.initials: M
authors.lastname: Martin